The neurotoxic effects of enzyme inhibitors at the neuromuscular junction

A sequential extraction technique was used to rapidly analyse AChE molecular form activity at the mouse neuromuscular junction and also in peripheral parts of muscle fibres. AChE in the synaptic cleft involved in the termination of cholinergic transmission was successfully assessed by the assay meth...

Full description

Bibliographic Details
Main Author: Rowbotham, A. L.
Published: Aston University 1997
Subjects:
Online Access:http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.497354
id ndltd-bl.uk-oai-ethos.bl.uk-497354
record_format oai_dc
spelling ndltd-bl.uk-oai-ethos.bl.uk-4973542017-04-20T03:29:24ZThe neurotoxic effects of enzyme inhibitors at the neuromuscular junctionRowbotham, A. L.1997A sequential extraction technique was used to rapidly analyse AChE molecular form activity at the mouse neuromuscular junction and also in peripheral parts of muscle fibres. AChE in the synaptic cleft involved in the termination of cholinergic transmission was successfully assessed by the assay method and by an alternative method using a correlation equation which represented the relationship between synaptic AChE and the prolongation of extra-cellular miniature endplate potentials. It was found that inhibition after in vivo Carbamate (CB) dosing could not be maintained during tissue analysis because CB-inhibited enzyme complexes decarbamoylated vary rapidly and could not be prevented even when maintained on ice. The methods employed did not therefore give a measure of inhibition but presented a profile of metabolic responses to continual, low dose CB treatment. Repetitive and continual infusion with low doses of the CBs: pyridostigmine and physostigmine induced a variety of effects on mouse skeletal muscle. Both compounds induced a mild myopathy in the mouse diaphragm during continual infusion which was characterised by endplate deformation without necrosis; such deformation persisted on termination of treatment but had recovered slightly 14 days later. Endplate and non-endplate AChE molecular forms displayed selective responses to CB treatment. During treatment endplate AChE was reduced whereas non-endplate AChE was largely unaffected, and after treatment, endplate AChE recovered, whereas non-endplate AChE was up-regulated. The mechanisms by which these responses become manifest are unclear but may be due to CB-induced effects on nerve-mediated muscle activity, neurotrophic factors or morphological and physiological changes which arise at the neuromuscular junction. As well as inhibiting AChE, CBs also influence the metabolism and regulation of the enzyme and induce persistent endplate deformation.616.744027PharmacologyAston Universityhttp://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.497354http://publications.aston.ac.uk/15379/Electronic Thesis or Dissertation
collection NDLTD
sources NDLTD
topic 616.744027
Pharmacology
spellingShingle 616.744027
Pharmacology
Rowbotham, A. L.
The neurotoxic effects of enzyme inhibitors at the neuromuscular junction
description A sequential extraction technique was used to rapidly analyse AChE molecular form activity at the mouse neuromuscular junction and also in peripheral parts of muscle fibres. AChE in the synaptic cleft involved in the termination of cholinergic transmission was successfully assessed by the assay method and by an alternative method using a correlation equation which represented the relationship between synaptic AChE and the prolongation of extra-cellular miniature endplate potentials. It was found that inhibition after in vivo Carbamate (CB) dosing could not be maintained during tissue analysis because CB-inhibited enzyme complexes decarbamoylated vary rapidly and could not be prevented even when maintained on ice. The methods employed did not therefore give a measure of inhibition but presented a profile of metabolic responses to continual, low dose CB treatment. Repetitive and continual infusion with low doses of the CBs: pyridostigmine and physostigmine induced a variety of effects on mouse skeletal muscle. Both compounds induced a mild myopathy in the mouse diaphragm during continual infusion which was characterised by endplate deformation without necrosis; such deformation persisted on termination of treatment but had recovered slightly 14 days later. Endplate and non-endplate AChE molecular forms displayed selective responses to CB treatment. During treatment endplate AChE was reduced whereas non-endplate AChE was largely unaffected, and after treatment, endplate AChE recovered, whereas non-endplate AChE was up-regulated. The mechanisms by which these responses become manifest are unclear but may be due to CB-induced effects on nerve-mediated muscle activity, neurotrophic factors or morphological and physiological changes which arise at the neuromuscular junction. As well as inhibiting AChE, CBs also influence the metabolism and regulation of the enzyme and induce persistent endplate deformation.
author Rowbotham, A. L.
author_facet Rowbotham, A. L.
author_sort Rowbotham, A. L.
title The neurotoxic effects of enzyme inhibitors at the neuromuscular junction
title_short The neurotoxic effects of enzyme inhibitors at the neuromuscular junction
title_full The neurotoxic effects of enzyme inhibitors at the neuromuscular junction
title_fullStr The neurotoxic effects of enzyme inhibitors at the neuromuscular junction
title_full_unstemmed The neurotoxic effects of enzyme inhibitors at the neuromuscular junction
title_sort neurotoxic effects of enzyme inhibitors at the neuromuscular junction
publisher Aston University
publishDate 1997
url http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.497354
work_keys_str_mv AT rowbothamal theneurotoxiceffectsofenzymeinhibitorsattheneuromuscularjunction
AT rowbothamal neurotoxiceffectsofenzymeinhibitorsattheneuromuscularjunction
_version_ 1718441173309194240